Neuberger Berman Group’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.8K | Buy |
17,153
+6,384
| +59% | +$32.3K | ﹤0.01% | 1967 |
|
|
2025
Q1 | $57K | Buy |
10,769
+469
| +5% | +$2.48K | ﹤0.01% | 1900 |
|
|
2024
Q4 | $69.6K | Sell |
10,300
-219,538
| -96% | -$1.48M | ﹤0.01% | 1864 |
|
|
2024
Q3 | $1.51M | Sell |
229,838
-125,801
| -35% | -$829K | ﹤0.01% | 1189 |
|
|
2024
Q2 | $2.67M | Buy |
+355,639
| New | +$2.67M | ﹤0.01% | 1046 |
|